切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2020, Vol. 09 ›› Issue (01) : 76 -79. doi: 10.3877/cma.j.issn.2095-3224.2020.01.015

所属专题: 文献

综述

溃疡性结肠炎的手术指征、手术方式及围手术期管理
赵锐1, 周勇1,()   
  1. 1. 610041 成都,四川大学华西医院胃肠外科
  • 收稿日期:2019-05-27 出版日期:2020-02-20
  • 通信作者: 周勇
  • 基金资助:
    四川省科技计划项目(No. 004020531F53)

Surgical indications, methods and perioperative management of ulcerative colitis

Rui Zhao1, Yong Zhou1,()   

  1. 1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
  • Received:2019-05-27 Published:2020-02-20
  • Corresponding author: Yong Zhou
引用本文:

赵锐, 周勇. 溃疡性结肠炎的手术指征、手术方式及围手术期管理[J]. 中华结直肠疾病电子杂志, 2020, 09(01): 76-79.

Rui Zhao, Yong Zhou. Surgical indications, methods and perioperative management of ulcerative colitis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2020, 09(01): 76-79.

溃疡性结肠炎是炎症性肠病(IBD)的一种表现类型,发病部位主要集中在结直肠,其并发症主要为出血、穿孔、癌变及反复发作引起梗阻。溃疡性结肠炎与克罗恩病不同,溃疡性结肠炎是可以通过手术而达到根治的,且手术后的复发率及并发症率都较低,手术对于溃疡性结肠炎的患者有着更重要的意义。而手术指征、手术方式和围手术期的管理与手术的效果及术后患者的生活质量都有着密切的关系,所以对外科医生的经验及技术提出了较高的要求。本文主要集中探讨外科治疗溃疡性结肠炎的手术指征、手术方式及围手术期处理等问题。

Ulcerative colitis is a manifestation of inflammatory bowel disease (IBD). The incidence of ulcerative colitis is mainly concentrated in the colon and rectum. Its complications are mainly hemorrhage, perforation, canceration and recurrence of obstruction. Ulcerative colitis is different from Crohn′s disease. Ulcerative colitis can be cured by operation, and the recurrence rate and complication rate after operation are low. Patients with ulcerative colitis have more important significance. The indications for surgery, the management of the operation and the management of the perioperative period have a close relationship with the effect of the operation and the life quality of the postoperative patients. Therefore, the surgeon′s experience and technology put forward higher requirements. This paper focuses on the surgical indications, surgical methods and perioperative management of ulcerative colitis.

[1]
Loddo I, Romano C. Inflammatory Bowel Disease: Genetsics, Epigenetsics, and Pathogenesis [J]. Frontiers in Immunology, 2015, 6: 551.
[2]
Ventham NT, Kennedy NA, Nimmo ER, et al. Beyond gene discovery in inflammatory bowel disease: The emerging role of epigenetics [J]. Gastroenterology, 2013, 145(2): 293-308.
[3]
Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation [J]. Nature Medicine, 2010, 16(1): 90-97.
[4]
McLeod RS. Surgery for inflammatory bowel diseases [J]. Digestive Diseases, 2003, 21(2): 168-179.
[5]
Frolkis AD, Dykeman J, Negron ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: A systematic review and Meta-analysis of population-based studies [J]. Gastroenterology, 2013, 145(5): 996-1006.
[6]
Bohl JL, Sobba K. Indications and options for surgery in ulcerative colitis [J]. Surgical Clinics of North America, 2015, 95(6): 1211-1232.
[7]
Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis [J]. Gut, 1992, 33(7): 938-941.
[8]
Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn′s disease of the colon [J]. Inflammatory Bowel Diseases, 2009, 15(4): 630-638.
[9]
Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence [J]. Gastroenterology, 2003, 124(2): 544-560.
[10]
Cohen JL, Strong SA, Hyman NH, et al. Practice parameters for the surgical treatment of ulcerative colitis [J]. Diseases of the Colon & Rectum, 2005, 48(11): 1997-2009.
[11]
Ross H, Steele SR, Varma M, et al. Practice parameters for the surgical treatment of ulcerative colitis [J]. Diseases of the Colon & Rectum, 2014, 57(1): 5-22.
[12]
Reiser JR, Waye JD, Janowitz HD, et al. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy [J]. American Journal of Gastroenterology, 1994, 89(1): 119-122.
[13]
Dignass A, Preiss JC, Aust DE, et al. Updated german guideline on diagnosis and treatment of ulcerative colitis, 2011 [J]. Zeitschrift Fur Gastroenterologie, 2011, 49(9): 1276-1341.
[14]
Dayan B, Turner D. Role of surgery in severe ulcerative colitis in the era of medical rescue therapy [J]. World Journal of Gastroenterology, 2012, 18(29): 3833-3838.
[15]
Gan SI, Beck PL. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management [J]. American Journal of Gastroenterology, 2003, 98(11): 2363-2371.
[16]
Juviler A, Hyman N. Ulcerative colitis: the fate of the retained rectum [J]. Clinics in Colon and Rectal Surgery, 2004, 17(1): 29-34.
[17]
Lee-Kong S, Kiran RP. Ongoing challenges and controversies in ulcerative colitis surgery [J]. Expert Review of Gastroenterology & Hepatology, 2016, 10(2): 187-191.
[18]
Bellolio RF, Zuniga AJ, Wagner HP, et al. Ileorectal anastomosis in the surgical treatment of ulcerative colitis: Long-term results [J]. Revista Medica De Chile, 2008, 136(9): 1121-1126.
[19]
Paoluzi OA, Di Paolo MC, Ricci F, et al. Ileo-rectal anastomosis in ulcerative colitis: results of a long-term follow-up study [J]. Italian Journal of Gastroenterology, 1994, 26(8): 392-397.
[20]
da Luz Moreira A, Kiran RP, Lavery I. Clinical outcomes of ileorectal anastomosis for ulcerative colitis [J]. British Journal of Surgery, 2010, 97(1): 65-69.
[21]
Wibmer AG, Kroesen AJ, Grone J, et al. Predictors of permanent ileostomy after restorative proctocolectomy [J]. British Journal of Surgery, 2010, 97(10): 1561-1566.
[22]
Burns EM, Bottle A, Aylin P, et al. Volume analysis of outcome following restorative proctocolectomy [J]. British Journal of Surgery, 2011, 98(3): 408-417.
[23]
Fichera A, Silvestri MT, Hurst RD, et al. Laparoscopic restorative proctocolectomy with ileal pouch anal anastomosis: A comparative observational study on long-term functional results [J]. Journal of Gastrointestinal Surgery, 2009, 13(3): 526-532.
[24]
Ahmed Ali U, Keus F, Heikens JT, et al. Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis [J]. Cochrane Database of Systematic Reviews, 2009: CD006267.
[25]
Larson DW, Davies MM, Dozois EJ, et al. Sexual function, body image, and quality of life after laparoscopic and open ileal pouch-anal anastomosis [J]. Diseases Of the Colon & Rectum, 2008, 51(4): 392-396.
[26]
El-Gazzaz GS, Kiran RP, Remzi FH, et al. Outcomes for case-matched laparoscopically assisted versus open restorative proctocolectomy [J]. British Journal of Surgery, 2009, 96(5): 522-526.
[27]
Alves A, Panis Y, Bouhnik Y, et al. Subtotal colectomy for severe acute colitis: A 20-year experience of a tertiary care center with an aggressive and early surgical policy [J]. Journal of the American College of Surgeons, 2003, 197(3): 379-385.
[28]
Hyman NH, Cataldo P, Osler T. Urgent subtotal colectomy for severe inflammatory bowel disease [J]. Diseases of the Colon & Rectum, 2005, 48(1): 70-73.
[29]
Marceau C, Alves A, Ouaissi M, et al. Laparoscopic subtotal colectomy for acute for severe colitis complicating inflammatory bowel disease: A case-matched study in 88 patients [J]. Surgery, 2007, 141(5): 640-644.
[30]
Telem DA, Vine AJ, Swain G, et al. Laparoscopic subtotal colectomy for medically refractory ulcerative colitis: the time has come [J]. Surgical Endoscopy And Other Interventional Techniques, 2010, 24(7): 1616-1620.
[31]
Cahill RA, Lindsey I, Jones O, et al. Single-port laparoscopic total colectomy for medically uncontrolled colitis [J]. Diseases of the Colon & Rectum, 2010, 53(8): 1143-1147.
[32]
Lau C, Dubinsky M, Melmed G, et al. The impact of preoperative serum anti-TNFalpha therapy levels on early postoperative outcomes in inflammatory bowel disease surgery [J]. Annals of Surgery, 2015, 261(3): 487-496.
[33]
Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis [J]. Journal of the American College of Surgeons, 2007, 204(5): 956-962.
[34]
Kunitake H, Hodin R, Shellito PC, et al. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications [J]. Journal of Gastrointestinal Surgery, 2008, 12(10): 1730-1736.
[35]
Narula N, Charleton D, Marshall JK. Meta-analysis: peri-operative anti-TNF treatment and post-operative complications in patients with inflammatory bowel disease [J]. Alimentary Pharmacology & Therapeutics, 2013, 37(11): 1057-1064.
[36]
Kappelman MD, Bousvaros A. Nutritional concerns in pediatric inflammatory bowel disease patients [J]. Molecular Nutrition & Food Research, 2008, 52(8): 867-874.
[37]
Salinas H, Dursun A, Konstantinidis I, et al. Does preoperative total parenteral nutrition in patients with ulcerative colitis produce better outcomes [J]. International Journal of Colorectal Disease, 2012, 27(11): 1479-1483.
[38]
Weimann A, Braga M, Harsanyi L, et al. ESPEN guidelines on enteral nutrition: Surgery including organ transplantation [J]. Clinical Nutrition, 2006, 25(2): 224-244.
[39]
Royall D, Greenberg GR, Allard JP, et al. Total enteral nutrition support improves body composition of patients with active Crohn's disease [J]. Journal of Parenteral And Enteral Nutrition, 1995, 19(2): 95-99.
[40]
Makhdoom ZA, Komar MJ, Still CD. Nutrition and enterocutaneous fistulas [J]. Journal of Clinical Gastroenterology, 2000, 31(3): 195-204.
[41]
Teubner A, Morrison K, Ravishankar HR, et al. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula [J]. British Journal of Surgery, 2004, 91(5): 625-631.
[42]
Buckman SA, Heise CP. Nutrition considerations surrounding restorative proctocolectomy [J]. Nutrition In Clinical Practice, 2010, 25(3): 250-256.
[43]
El Muhtaseb MS, Duncan A, Talwar DK, et al. Assessment of dietary intake and trace element status in patients with ileal pouch-anal anastomosis [J]. Diseases of the Colon & Rectum, 2007, 50(10): 1553-1557.
[44]
Montgomery SC, Williams CM, Maxwell PJt. Nutritional support of patient with inflammatory bowel disease [J]. Surgical Clinics of North America, 2015, 95(6): 1271-1279.
[45]
Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study [J]. Gastroenterology, 2005, 128(7): 1805-1811.
[46]
Ventham NT, Kalla R, Kennedy NA, et al. Predicting outcomes in acute severe ulcerative colitis [J]. Expert Review of Gastroenterology & Hepatology, 2015, 9(4): 405-415.
[47]
Subramanian V, Saxena S, Kang JY, et al. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery [J]. American Journal of Gastroenterology, 2008, 103(9): 2373-2381.
[48]
Subramanian V, Pollok RC, Kang JY, et al. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators [J]. British Journal of Surgery, 2006, 93(7): 793-799.
[49]
Carter MJ, Lobo AJ, Travis SP, et al. Guidelines for the management of inflammatory bowel disease in adults [J]. Gut, 2004, 53(Suppl 5): V1-16.
[50]
Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study [J]. Lancet, 2010, 375(9715): 657-663.
[51]
Bernstein CN, Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada [J]. Canadian Journal of Gastroenterology, 2007, 21(8): 507-511.
[52]
Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients [J]. American Journal of Gastroenterology, 2008, 103(9): 2272-2280.
[1] 曹钰彬, 潘剑. 阻生牙拔除的为与不为[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 389-393.
[2] 杜晓辉, 晏阳. 腹腔镜低位和超低位直肠术式选择与原则[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 477-479.
[3] 蒋春艳, 赵刚, 诸国萍, 付庆辉, 卫建华. 等待心脏移植患者术前行右心漂浮导管检查临床应用及护理策略分析[J]. 中华移植杂志(电子版), 2023, 17(03): 164-168.
[4] 张剑明, 叶文慧, 牟廷裕, 蓝孝亮, 邓海军. 腹腔镜全结直肠切除、回肠J型储袋-肛管吻合术近期并发症及防治策略[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 388-395.
[5] 中华医学会骨科分会关节学组. 中国髋、膝关节置换日间手术围手术期管理专家共识[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 321-332.
[6] 黄秉志, 陈楠楠. 髋部骨折术后肺炎发生的危险因素分析[J]. 中华老年骨科与康复电子杂志, 2022, 08(06): 338-344.
[7] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[8] 朱风尚, 舍玲, 丁永年, 杨长青. 警惕炎症性肠病与少见肠道疾病的鉴别诊断[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 273-276.
[9] 陈婷婷, 江学良, 余佳丽, 柯剑林. 干细胞治疗炎症性肠病的安全性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 193-198.
[10] 余佳丽, 江学良. 从炎症性肠病治疗策略转变看生物制剂应用进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 129-134.
[11] 江学良, 柯剑林, 陈婷婷, 余佳丽. 不同剂量双歧杆菌四联活菌片对轻、中度活动期溃疡性结肠炎患者肠道菌群失调的影响[J]. 中华消化病与影像杂志(电子版), 2022, 12(05): 260-264.
[12] 王梦, 徐东燕, 张晓雨, 赵海剑. 伴有肛周疾病的炎症性肠病患者肛门功能及生活质量分析[J]. 中华消化病与影像杂志(电子版), 2022, 12(04): 224-227.
[13] 骆云凯, 陈剑. 静脉曲张的治疗进展[J]. 中华临床医师杂志(电子版), 2022, 16(04): 368-371.
[14] 房修罗, 赵太云, 陆兴俊. 康复新液联合美沙拉嗪对溃疡性结肠炎活动期患者HMGB1、MCP-1、SOCS-3和Beclin1表达的影响[J]. 中华临床医师杂志(电子版), 2022, 16(03): 246-251.
[15] 陈笑, 柳常青, 周杭城, 李田, 孙效辉, 吴明胜, 徐粮东, 徐美青, 解明然. 肺腺癌气腔播散的研究现状[J]. 中华胸部外科电子杂志, 2023, 10(02): 126-130.
阅读次数
全文


摘要